Skip to main content
Log on / register
Feedback
|
Support
|
My details
home
|
journals A-Z
|
subject areas
|
advanced search
|
authors
|
reviewers
|
libraries
|
jobs
|
about
|
my BioMed Central
|
home
|
journals A-Z
|
subject areas
|
advanced search
|
authors
|
reviewers
|
libraries
|
jobs
|
about
|
my BioMed Central
Quick Search
Current Opinion in Drug Discovery & Development
BioMed Central
PubMed Central
PubMed
Jump to article
vol.
page no.
Current Opinion in Drug Discovery & Development
Home
Journal site
Advanced search
Archive
About this journal
Most viewed
Article alerts
Current Opinion in Drug Discovery & Development, Volume 11, Issue 4 (July 2008)
[
more info
]
Current Opinion in Drug Discovery & Development is published bimonthly and focuses on the chemical aspects of drug discovery and development.
Access to the full text or PDF of articles from
Current Opinion in Drug Discovery & Development
requires a
subscription
to the journal.
previous issue
next issue
Paper alert
Paper alert
P Norman, DP Rotella, B Sherborne
Current Opinion in Drug Discovery and Development
2008,
11
:407-420
(30
June
2008)
[
PDF
]
Patent alert
Patent alert
Reuters Current Awareness Analysts Thomson
Current Opinion in Drug Discovery and Development
2008,
11
:421-433
(30
June
2008)
[
PDF
]
Web alert
Web alert
TDY Chung
Current Opinion in Drug Discovery and Development
2008,
11
:434-435
(30
June
2008)
[
PDF
]
Review
Rediscovering the role of natural products in drug discovery
MC Desai, S Chackalamannil
Current Opinion in Drug Discovery and Development
2008,
11
:436-437
(30
June
2008)
[
PDF
]
[
PubMed
]
[
Related articles
]
Review
Agonists of the serotonin 5-HT2C receptor: Preclinical and clinical progression in multiple diseases
DA Wacker, KJ Miller
Current Opinion in Drug Discovery and Development
2008,
11
:438-445
(30
June
2008)
[
PDF
]
[
PubMed
]
[
Related articles
]
Review
Recent progress in the discovery of selective, non-peptide ligands of somatostatin receptors
SE Wolkenberg, CJ Thut
Current Opinion in Drug Discovery and Development
2008,
11
:446-457
(30
June
2008)
[
PDF
]
[
PubMed
]
[
Related articles
]
Review
Improving non-nucleoside reverse transcriptase inhibitors for first-line treatment of HIV infection: The development pipeline and recent clinical data
ZK Sweeney, K Klumpp
Current Opinion in Drug Discovery and Development
2008,
11
:458-470
(30
June
2008)
[
PDF
]
[
PubMed
]
[
Related articles
]
Review
Integrase inhibitors for the treatment of HIV infection
P Pace, M Rowley
Current Opinion in Drug Discovery and Development
2008,
11
:471-479
(30
June
2008)
[
PDF
]
[
PubMed
]
[
Related articles
]
Review
TAFIa inhibitors in the treatment of thrombosis
ME Bunnage, DR Owen
Current Opinion in Drug Discovery and Development
2008,
11
:480-486
(30
June
2008)
[
PDF
]
[
PubMed
]
[
Related articles
]
Review
Targeting myostatin for therapies against muscle-wasting disorders
K Tsuchida
Current Opinion in Drug Discovery and Development
2008,
11
:487-494
(30
June
2008)
[
PDF
]
[
PubMed
]
[
Related articles
]
Review
Recent advances in the discovery of 11b-HSD1 inhibitors
CD Boyle
Current Opinion in Drug Discovery and Development
2008,
11
:495-511
(30
June
2008)
[
PDF
]
[
PubMed
]
[
Related articles
]
Review
From the bench to the bedside: Dipeptidyl peptidase IV inhibitors, a new class of oral antihyperglycemic agents
Z Pei
Current Opinion in Drug Discovery and Development
2008,
11
:512-532
(30
June
2008)
[
PDF
]
[
PubMed
]
[
Related articles
]
Review
Glycogen synthase kinase-3 (GSK-3) inhibitors reach the clinic
M Medina, A Castro
Current Opinion in Drug Discovery and Development
2008,
11
:533-543
(30
June
2008)
[
PDF
]
[
PubMed
]
[
Related articles
]
Review
Conformationally based design of macrocycles as antitumor agents
EK Singh, RP Sellers, LD Alexander, SR McAlpine
Current Opinion in Drug Discovery and Development
2008,
11
:544-552
(30
June
2008)
[
PDF
]
[
PubMed
]
[
Related articles
]
Review
The impact of diversity-based, high-throughput screening on drug discovery: "Chance favours the prepared mind"
M Snowden, DVS Green
Current Opinion in Drug Discovery and Development
2008,
11
:553-558
(30
June
2008)
[
PDF
]
[
PubMed
]
[
Related articles
]
Review
From virtuality to reality
Virtual screening in lead discovery and lead optimization: A medicinal chemistry perspective
U Rester
Current Opinion in Drug Discovery and Development
2008,
11
:559-568
(30
June
2008)
[
PDF
]
[
PubMed
]
[
Related articles
]
Review
Exploiting QSAR models in lead optimization
P Gedeck, RA Lewis
Current Opinion in Drug Discovery and Development
2008,
11
:569-575
(30
June
2008)
[
PDF
]
[
PubMed
]
[
Related articles
]
previous issue
next issue
Terms and Conditions
Privacy statement
Information for advertisers
Jobs at BMC
Contact us
© 1999-2008 BioMed Central Ltd unless otherwise stated
previous issue
Virtual screening in lead discovery and lead optimization: A medicinal chemistry perspective